A detailed history of Balyasny Asset Management LLC transactions in Quanterix Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 767,801 shares of QTRX stock, worth $3.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
767,801
Previous 44,506 1625.16%
Holding current value
$3.65 Million
Previous $289,000 1666.44%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$4.28 - $6.72 $3.1 Million - $4.86 Million
723,295 Added 1625.16%
767,801 $5.11 Million
Q1 2025

May 15, 2025

BUY
$6.51 - $12.08 $90,332 - $167,622
13,876 Added 45.3%
44,506 $289,000
Q4 2024

Feb 14, 2025

SELL
$9.99 - $15.39 $108,601 - $167,304
-10,871 Reduced 26.19%
30,630 $325,000
Q3 2024

Nov 14, 2024

BUY
$10.92 - $16.36 $453,190 - $678,956
41,501 New
41,501 $537,000
Q4 2023

Feb 14, 2024

BUY
$19.54 - $28.66 $556,811 - $816,695
28,496 New
28,496 $779,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $176M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.